[PLX] QoQ Quarter Result on 30-Sep-2009 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-Nov-2009
Financial Year
2009
Quarter
30-Sep-2009 [#Q3]
Profit Trend
QoQ- -8.61%
YoY- 9.27%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
Revenue 1,141 1,141 388 0 0 0 0 -
PBT 0 -7,955 31,440 0 0 0 9,390 -
Tax -109 0 -16,504 -152 -446 148 -15,838 -96.41%
NP -10,041 -7,955 -14,936 -5,894 -5,427 -5,183 -6,576 32.70%
Tax Rate - - 52.49% - - - 168.67% -
Total Cost 11,182 9,096 15,324 5,894 5,427 5,183 6,576 42.60%
Ratio Analysis
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
NP Margin -880.02 -697.20 -3,849.48 0.00 0.00 0.00 0.00 -
Per Share
30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 31/12/08 CAGR
EPS -0.12 -0.10 -1.85 -0.08 -0.07 -0.07 -0.87 -73.40%
EPS Diluted -0.12 -0.10 -1.85 -0.08 -0.07 -0.07 -0.87 -73.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.